Evidence-Based Medicine Guidelines
Neuroleptic malignant syndrome (NMS)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Neuroleptic Malignant Syndrome (NMS)." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454986/all/_________Neuroleptic_malignant_syndrome__NMS_______.
Neuroleptic malignant syndrome (NMS). Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/454986/all/_________Neuroleptic_malignant_syndrome__NMS_______. Accessed November 25, 2024.
Neuroleptic malignant syndrome (NMS). (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454986/all/_________Neuroleptic_malignant_syndrome__NMS_______
Neuroleptic Malignant Syndrome (NMS) [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454986/all/_________Neuroleptic_malignant_syndrome__NMS_______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neuroleptic malignant syndrome (NMS)
ID - 454986
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454986/all/_________Neuroleptic_malignant_syndrome__NMS_______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
